Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.767 CHF
1.28 B CHF
249.11 B CHF
185.70 M
About Cencora, Inc.
Sector
Industry
CEO
Robert P. Mauch
Website
Headquarters
Conshohocken
Founded
1947
ISIN
US03073E1055
FIGI
BBG00LVD70L9
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ABC4213751
Cencora, Inc. 4.25% 01-MAR-2045Yield to maturity
5.80%
Maturity date
Mar 1, 2045
ABC4571978
Cencora, Inc. 4.3% 15-DEC-2047Yield to maturity
5.64%
Maturity date
Dec 15, 2047
ABC5953320
Cencora, Inc. 5.15% 15-FEB-2035Yield to maturity
4.92%
Maturity date
Feb 15, 2035
ABC5748091
Cencora, Inc. 5.125% 15-FEB-2034Yield to maturity
4.81%
Maturity date
Feb 15, 2034
ABC5156681
Cencora, Inc. 2.7% 15-MAR-2031Yield to maturity
4.45%
Maturity date
Mar 15, 2031
ABC5953319
Cencora, Inc. 4.85% 15-DEC-2029Yield to maturity
4.33%
Maturity date
Dec 15, 2029
ABC4987224
Cencora, Inc. 2.8% 15-MAY-2030Yield to maturity
4.32%
Maturity date
May 15, 2030
ABC4571977
Cencora, Inc. 3.45% 15-DEC-2027Yield to maturity
4.18%
Maturity date
Dec 15, 2027
ABC5953643
Cencora, Inc. 4.625% 15-DEC-2027Yield to maturity
4.06%
Maturity date
Dec 15, 2027
XS307124637
Cencora, Inc. 3.625% 22-MAY-2032Yield to maturity
3.50%
Maturity date
May 22, 2032
XS307124629
Cencora, Inc. 2.875% 22-MAY-2028Yield to maturity
2.77%
Maturity date
May 22, 2028
See all ABG bonds
Frequently Asked Questions
The current price of ABG is 229.667 CHF — it has decreased by −1.01% in the past 24 hours. Watch Cencora, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange Cencora, Inc. stocks are traded under the ticker ABG.
ABG stock has fallen by −1.01% compared to the previous week, the month change is a −1.01% fall, over the last year Cencora, Inc. has showed a 15.78% increase.
We've gathered analysts' opinions on Cencora, Inc. future price: according to them, ABG price has a max estimate of 279.24 CHF and a min estimate of 243.84 CHF. Watch ABG chart and read a more detailed Cencora, Inc. stock forecast: see what analysts think of Cencora, Inc. and suggest that you do with its stocks.
ABG stock is 1.02% volatile and has beta coefficient of 0.18. Track Cencora, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cencora, Inc. there?
Today Cencora, Inc. has the market capitalization of 47.54 B, it has decreased by −3.66% over the last week.
Yes, you can track Cencora, Inc. financials in yearly and quarterly reports right on TradingView.
Cencora, Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ABG earnings for the last quarter are 3.17 CHF per share, whereas the estimation was 3.05 CHF resulting in a 3.96% surprise. The estimated earnings for the next quarter are 3.01 CHF per share. See more details about Cencora, Inc. earnings.
Cencora, Inc. revenue for the last quarter amounts to 64.00 B CHF, despite the estimated figure of 63.55 B CHF. In the next quarter, revenue is expected to reach 66.39 B CHF.
ABG net income for the last quarter is 545.38 M CHF, while the quarter before that showed 635.49 M CHF of net income which accounts for −14.18% change. Track more Cencora, Inc. financial stats to get the full picture.
Yes, ABG dividends are paid quarterly. The last dividend per share was 0.44 CHF. As of today, Dividend Yield (TTM)% is 0.71%. Tracking Cencora, Inc. dividends might help you take more informed decisions.
Cencora, Inc. dividend yield was 0.91% in 2024, and payout ratio reached 27.07%. The year before the numbers were 1.08% and 22.74% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 26, 2025, the company has 46 K employees. See our rating of the largest employees — is Cencora, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cencora, Inc. EBITDA is 3.60 B CHF, and current EBITDA margin is 1.41%. See more stats in Cencora, Inc. financial statements.
Like other stocks, ABG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cencora, Inc. stock right from TradingView charts — choose your broker and connect to your account.